Usman Hayat writes about sustainable, responsible, and impact investing and Islamic finance. He is the lead author of "Environmental, Social, and Governance Issues in Investing: A Guide for Investment Professionals," and the literature review, "Islamic Finance: Ethics, Concepts, Practice." He is interested in online learning and has directed three e-courses for CFA Institute: "ESG-100," "Islamic Finance Quiz," and "Residual Income Equity Valuation." The other topics he writes about are macroeconomics and behavioral finance. Previously, he was a content director at CFA Institute. He is a former executive director at the Securities and Exchange Commission of Pakistan (SECP). He has experience working in securities regulation and as an independent consultant. His qualifications include the CFA charter, the FRM designation, an MBA, and an MA in Development Economics. His personal interests are reading and hiking.
Subscribe to Enterprising Investor and receive the weekly email newsletter.
The Bank of England will not resort to printing money to lessen the economic impact of the coronavirus pandemic, Governor Andrew Bailey says. "Using monetary financing would damage credibility on controlling inflation by eroding operational independence," Bailey says. Reuters (05 Apr.)
Securities and Exchange Commission member Allison Herren Lee wants the agency to pause pending rule changes but not rush into regulatory relief without analysis amid the coronavirus pandemic. "Relevant considerations in that analysis include whether an action is directly responsive to COVID-19 and whether an action represents an appropriate use of agency resources at a time when we are routinely called upon to take emergency actions," she says. Reuters (04 Apr.)
If the US has any shortage of drugs, it is because of high demand and not because China or any other country is preventing the supply of ingredients, says Stephen Hahn, head of the US Food and Drug Administration. "We don't have any evidence that there is a drug in short supply because of anyone blocking the active pharmaceutical ingredients in the drugs," he says. BNN Bloomberg (Canada) (05 Apr.)
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.